Regulatory Affairs2023年9月11日 4 分钟
Oncolytic viruses: the use for cancer immunotherapy
Oncolytic viruses and cellular immunotherapy show promise in cancer care. Learn their mechanisms, risks, and key biosafety requirements.
阅读更多
Regulatory Affairs2022年2月1日 11 分钟
CAR-T cell therapy: main components, manufacturing, and prospects
CAR-T cell therapy uses genetically engineered T cells to destroy tumor cells. Learn more about the main components and manufacturing process.
阅读更多
2020年10月6日 4 分钟
Is your ATMP platform robust enough to deal with material input variability?
Selecting the appropriate starting and raw materials for ATMPs is a crucial step to prevent delays, repetition of work or to avoid unforeseen costs during upscaling.
阅读更多